Table 1:

Overall Cohort Demographics for Emergency Department Asthma Visits

Variable	Overall cohort (n=3948 visits*) (%)	Received ICS+ prescription (n=238, 6%) (%)	Did not receive ICS+ prescription (n=3710, 94%) (%)
Female sex	60.0	63.0	59.8
Age Category
18-39 years	44.4	36.6	44.9
40-64 years	39.6	46.6	39.2
65 years and older	16.0	16.8	15.9
Race/Ethnicity
Black or African American	44.9	49.6	44.6
White	8.3	8.0	8.4
Hispanic	34.4	30.3	35.6
Asian	2.0	2.1	2.0
Other	10.5	10.1	10.5
Primary Language
English	91.8	92.9	91.8
Insurance Type
Medicaid	40.9	45.8	40.8
Medicare	17.9	19.3	17.8
Private	26.8	22.7	27.0
None/Uninsured	10.2	6.7	10.5
Other	4.2	5.5	4.2
Smoking status
Current or former smoker	19.9	22.3	19.7
Charlson Comorbidity Score
2 or more	10.3	12.2	10.2
Primary Care Provider
Documented in Electronic Health Record	48.7	48.3	48.7
Medications received in ED
Received SABA& in ED	92.6	91.2	92.6
Received oral steroid in ED	72.6	71.0	72.8
Received ICS+ in ED	2.5	13.0	1.8
Discharge prescription for oral steroid	66.8	76.1	66.2
Discharge prescription for SABA &	64.6	81.1	63.6
Outpatient visit within 30 days	14.0	16.0	13.9
ED revisit within 30 days	3.8	4.6	3.7

^*There were 3,948 visits among 2,999 unique patients.

⁺ICS = Inhaled Corticosteroid

^&SABA = Short Acting Beta Agonist